Login to Your Account



As Pfizer Changes, Biotech Partners Seem Unaffected

By Karen Pihl-Carey


Monday, December 4, 2006
A loss of exclusivity, strong competition and a changing market led Pfizer Inc. to cut its U.S. sales force by 20 percent last week, yet analysts say the move should have little impact - if any - on the biotech community. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription